Xtandi Union européenne - bulgare - EMA (European Medicines Agency)

xtandi

astellas pharma europe b.v. - enzalutamide - Простатни неоплазми - Ендокринна терапия - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.

Namuscla Union européenne - bulgare - EMA (European Medicines Agency)

namuscla

lupin europe gmbh - mexiletine hydrochloride - Миотонических Нарушения - Сърдечна терапия - namuscla е показан за симптоматично лечение на миотонии при възрастни пациенти с не-дистрофические миотонических нарушения.

Biprol  10 mg film-coated tablets Bulgarie - bulgare - Изпълнителна агенция по лекарствата

biprol  10 mg film-coated tablets

Нео Балканика ЕООД - Бисопролол - 10 mg film-coated tablets

Biprol  5 mg film-coated tablets Bulgarie - bulgare - Изпълнителна агенция по лекарствата

biprol  5 mg film-coated tablets

Нео Балканика ЕООД - Бисопролол - 5 mg film-coated tablets